These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 215354)

  • 21. [Postoperative hypoparathyroidism well responding to 1 alpha-OH-D3--a case report-- (author's transl)].
    Asahina S; Tanaka K; Shionoiri H; Kaneko Y; Manabe Y
    Horumon To Rinsho; 1980 Aug; 28(8):939-42. PubMed ID: 7460341
    [No Abstract]   [Full Text] [Related]  

  • 22. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium imbalance in hypoparathyroidism.
    Gupta MM
    J Assoc Physicians India; 1991 Aug; 39(8):616-8. PubMed ID: 1669288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of clinical remission in patients with sporadic idiopathic hypoparathyroidism.
    Goswami R; Goel S; Tomar N; Gupta N; Lumb V; Sharma YD
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):328-33. PubMed ID: 19549251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [1 alpha, 25-dihydroxyvitamin D3 for hypoparathyroidism. Optimal maintenance dosage].
    Sohn HE; Miura R; Yumida S; Furukawa Y
    Horumon To Rinsho; 1983 Aug; 31(8):809-14. PubMed ID: 6688769
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]].
    Irino S; Taoka T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual case of paroxysmal kinesigenic dyskinesia.
    Thomas R; Behari M; Gaikwad SB; Prasad K
    J Clin Neurosci; 2002 Jan; 9(1):94-7. PubMed ID: 11749031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hypoparathyroidism with 1 alpha, 25-dihydroxyvitamin D3 (author's transl)].
    Sohn HE; Miura Y; Yumida S; Unagami H; Furukawa Y
    Horumon To Rinsho; 1982 Jan; 30(1):87-92. PubMed ID: 6896176
    [No Abstract]   [Full Text] [Related]  

  • 29. [The therapy of hypoparathyroidism with basal ganglion calcification].
    Ringe JD
    Dtsch Med Wochenschr; 1992 Sep; 117(38):1459. PubMed ID: 1326432
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of the main derivatives of vitmain D in 3 siblings with "pseudo-deficiency" rickets].
    Dommergues JP; Garabedian M; Gueris J; Le Deunff MJ; Creignou L; Courtecuisse V; Balsan S
    Arch Fr Pediatr; 1978 Dec; 35(10):1050-62. PubMed ID: 219799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parathyroid hormone and 25-hydroxy-cholecalciferol during hypoparathyroidism].
    Argemi B; Naim C; N'guyen K; Staub J; Gras C; Simonin R
    Nouv Presse Med; 1977 May; 6(22):1979. PubMed ID: 887398
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic effect of 1,25-dihydroxyvitamin D3 on hypoparathyroidism].
    Okano K; Nawa C; Ko K; Yamada Y; Sekita N
    Horumon To Rinsho; 1983 Apr; 31(4):393-8. PubMed ID: 6688385
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypoparathyroidism associated with autoimmune disorder].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2007 Aug; 17(8):1193-9. PubMed ID: 17660615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of treatment with 25 OH D3 in a case of chronic hypoparathyroidism slightly responsive to treatment with vitamin D].
    Cataldo F; Scotto E; De Gregorio T; Albeggiani A
    Pediatria (Napoli); 1982 Sep; 90(3):295-302. PubMed ID: 7155703
    [No Abstract]   [Full Text] [Related]  

  • 35. 25-hydroxycholecalciferol.
    JAMA; 1970 Aug; 213(9):1480-1. PubMed ID: 4317759
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preparations for treatment of hypoparathyreoidism (antitetanics). 36].
    Götz HG
    Pharm Prax; 1969; 7():158-60. PubMed ID: 4309760
    [No Abstract]   [Full Text] [Related]  

  • 37. Myogenic hyperuricemia in hypoparathyroidism.
    Nishimura T; Mineo I; Shimizu T; Kawachi M; Ono A; Nakajima H; Kuwajima M; Kono N; Tarui S
    Adv Exp Med Biol; 1991; 309A():213-6. PubMed ID: 1665007
    [No Abstract]   [Full Text] [Related]  

  • 38. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women.
    Tjellesen L; Hummer L; Christiansen C; Rødbro P
    Bone Miner; 1986 Oct; 1(5):407-13. PubMed ID: 2849489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Today's drugs.
    Br Med J; 1969 Mar; 1(5643):562-3. PubMed ID: 4304218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.